Novel beta lactamase inhibitors to combat antibiotic resistance

新型β内酰胺酶抑制剂可对抗抗生素耐药性

• 批准号: 188103
• 负责人: Dmitrienko Gary I
• 金额: $ 10.93万
• 依托单位: University of Waterloo (Ontario)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2009
• 资助国家: 加拿大
• 起止时间: 2009-04-01 至 2010-04-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=188103&lang=en
• 关键词: Antibiotic Drugs; Enzyme Inhibitors; Microbiological Assays

The carbapenems, antibiotics developed in the past to overcome bacterial resistance and employed judiciously as last line of defence antibacterials in severe hospital-acquired infections, are now becoming ineffective. Some bacterial strains have developed

碳青霉烯类抗生素是过去为克服细菌耐药性而开发的，并被明智地用作最后一道防线